Xeris Biopharma Holdings, Inc. (XERS)

6.00 +0.06 (+1.01%) USD  |  NASDAQ  |  Mar 04, 14:24
More

Xeris Biopharma Holdings Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
IDEXX Laboratories, Inc. Upgrade
Harrow, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade